Anthrax Lethal Factor

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (11:38, 3 March 2024) (edit) (undo)
 
(10 intermediate revisions not shown.)
Line 1: Line 1:
-
{{STRUCTURE_1j7n| PDB=1j7n | SIZE=500| SCENE= |right|CAPTION=Anthrax toxin lethal factor dimer complex with sulfate and Zn+2 ions (grey) [[1j7n]] }}
+
<StructureSection load='1j7n' size='340' side='right' scene='' caption='Anthrax toxin lethal factor dimer complex with sulfate and Zn+2 ions (grey) [[1j7n]]'>
 +
 
__TOC__
__TOC__
==Introduction==
==Introduction==
----------------
----------------
-
'''Anthrax Lethal Factor''' (LF) is one of the enzymatic components belonging to the [http://en.wikipedia.org/wiki/Anthrax_toxin Anthrax Toxin]. Anthrax toxin is a three component exotoxin secreted by the bacterium [http://en.wikipedia.org/wiki/Bacillus_anthracis ''Bacillus Anthracis''] made up of a binding protein, protective antigen (PA) and two enzyme components edema factor (EF) and lethal factor (LF). <ref name=Collier>PMID: 14570563</ref>
+
'''Anthrax Lethal Factor''' (LF) is one of the enzymatic components belonging to the [http://en.wikipedia.org/wiki/Anthrax_toxin Anthrax Toxin]. Anthrax toxin is a three component exotoxin secreted by the bacterium [http://en.wikipedia.org/wiki/Bacillus_anthracis ''Bacillus Anthracis''] made up of a binding protein, [[Anthrax protective antigen|protective antigen]] (PA) and two enzyme components [[Anthrax edema factor|edema factor]] (EF) and lethal factor (LF). <ref name=Collier>PMID: 14570563</ref> See also [[Toxins]].
Anthrax Toxin, encoded by plasmid pXO1, is considered an AB toxin, with two A domains (EF and LF) and one B domain (PA). <ref name=Collier>PMID: 14570563</ref> <ref>Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach</ref> On their own, these three domains are nontoxic, but any combination involving PA with EF and/or LF is what causes the physiological effects. <ref>Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html</ref> Initially PA is a 83kDa protein which binds to the host Anthrax toxin Receptor (ATR). Upon binding, PA is cleaved into two fragments by furin proteases to become a 63 kDa protein bound to the ATR. Cleavage of PA allows self association to occur which forms a ring shaped heptamer know as the pore precursor (prepore). The prepore is now able to bind up to three molecules of EF and/or LF, leading to endocytosis of the complex. In the endosome, the prepore converts to a transmembrane pore, allowing translocation of EF and LF to the cytosol of target cell through a mechanism that is not well understood. EF and LF are now able to carry out their enzymatic activity on the host cell. <ref name=Collier>PMID: 14570563</ref>
Anthrax Toxin, encoded by plasmid pXO1, is considered an AB toxin, with two A domains (EF and LF) and one B domain (PA). <ref name=Collier>PMID: 14570563</ref> <ref>Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach</ref> On their own, these three domains are nontoxic, but any combination involving PA with EF and/or LF is what causes the physiological effects. <ref>Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html</ref> Initially PA is a 83kDa protein which binds to the host Anthrax toxin Receptor (ATR). Upon binding, PA is cleaved into two fragments by furin proteases to become a 63 kDa protein bound to the ATR. Cleavage of PA allows self association to occur which forms a ring shaped heptamer know as the pore precursor (prepore). The prepore is now able to bind up to three molecules of EF and/or LF, leading to endocytosis of the complex. In the endosome, the prepore converts to a transmembrane pore, allowing translocation of EF and LF to the cytosol of target cell through a mechanism that is not well understood. EF and LF are now able to carry out their enzymatic activity on the host cell. <ref name=Collier>PMID: 14570563</ref>
Line 22: Line 23:
PA+LF+EF Leads to lethal activity and edema
PA+LF+EF Leads to lethal activity and edema
 +
 +
See also [[Anthrax Lethal Factor (hebrew)]].
==Human Interaction==
==Human Interaction==
Line 36: Line 39:
==Treatments==
==Treatments==
-
Antibiotics are used to treat Cutaneous, if infection spreads and Inhalation Anthrax infections. The primary antibiotics used are Ciprofloxacin and Doxycycline. Antibiotics should be administered before symptoms arise, because it will decrease the fatality rate. In the case of inhalation, treatment should be received within 24 hours because the bacteria can rapidly spread. Treatment includes a 60 day course of antibiotics to ensure all spores have germinated. In some cases more than two antibiotics are administered. <ref>CDC. http://www.bt.cdc.gov/agent/anthrax/faq/treatment.asp</ref>.
+
Antibiotics are used to treat Cutaneous, if infection spreads and Inhalation Anthrax infections. The primary antibiotics used are [[Ciprofloxacin]] and [[Doxycycline]]. Antibiotics should be administered before symptoms arise, because it will decrease the fatality rate. In the case of inhalation, treatment should be received within 24 hours because the bacteria can rapidly spread. Treatment includes a 60 day course of antibiotics to ensure all spores have germinated. In some cases more than two antibiotics are administered. <ref>CDC. http://www.bt.cdc.gov/agent/anthrax/faq/treatment.asp</ref>.
Line 69: Line 72:
--------------
--------------
The most will known case of biological warfare in recent times occurred in 2001, known as [http://en.wikipedia.org/wiki/2001_anthrax_attacks Amerithrax]. Anthrax spores are a top choice for biological warfare because their potency. Production of these spores are among the easiest of bioterror agents. <ref>Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach</ref> They can be manipulated and produced in large quantities using basic microbiology techniques. Naturally occurring spores tend to aggregate making them less infection; they can easily be refined and dispersed. Because the anthrax spores are very robust; being able to survive for decades and are difficult to destroy, makes them excellent bioweapons. <ref>Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach</ref> <ref>Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html</ref>
The most will known case of biological warfare in recent times occurred in 2001, known as [http://en.wikipedia.org/wiki/2001_anthrax_attacks Amerithrax]. Anthrax spores are a top choice for biological warfare because their potency. Production of these spores are among the easiest of bioterror agents. <ref>Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach</ref> They can be manipulated and produced in large quantities using basic microbiology techniques. Naturally occurring spores tend to aggregate making them less infection; they can easily be refined and dispersed. Because the anthrax spores are very robust; being able to survive for decades and are difficult to destroy, makes them excellent bioweapons. <ref>Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach</ref> <ref>Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html</ref>
-
</StructureSection>
+
 
== 3D structures of anthrax lethal factor==
== 3D structures of anthrax lethal factor==
 +
[[Anthrax lethal factor 3D structures]]
-
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
+
</StructureSection>
-
 
+
-
[[1j7n]] – BaALF – ''Bacillus anthracis'' <br />
+
-
[[2l0r]] – BaALF catalytic domain – NMR<br />
+
-
[[1pwp]], [[1pwq]], [[1pwu]], [[1zxv]], [[4dv8]] – BaALF + inhibitor <br />
+
-
[[1yqy]] – BaALF domains II-IV + inhibitor <br />
+
-
[[4pkq]] - BaALF domain III (mutant) + Zn<br />
+
-
[[4pkr]], [[4pks]], [[4pkt]], [[4pku]], [[4pkv]], [[4pkw]] - BaALF domain III (mutant) + inhibitor<br />
+
-
[[1pww]], [[1pwv]] – BaALF + peptide substrate <br />
+
-
[[3kwv]] – BaALF protective antigen-binding domain + protective antigen <br />
+
-
[[1yqy]] – BaALF domain IV - NMR<br />
+
-
 
+
==References==
==References==

Current revision

Anthrax toxin lethal factor dimer complex with sulfate and Zn+2 ions (grey) 1j7n

Drag the structure with the mouse to rotate

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 Collier RJ, Young JA. Anthrax toxin. Annu Rev Cell Dev Biol. 2003;19:45-70. PMID:14570563 doi:10.1146/annurev.cellbio.19.111301.140655
  2. Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach
  3. Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
  4. Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
  5. Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
  6. Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
  7. Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
  8. Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
  9. Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
  10. Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
  11. Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
  12. Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
  13. Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html
  14. CDC. http://www.bt.cdc.gov/agent/anthrax/faq/treatment.asp
  15. Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
  16. Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
  17. Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
  18. Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
  19. Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
  20. Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Crystal structure of the anthrax lethal factor. Nature. 2001 Nov 8;414(6860):229-33. PMID:11700563 doi:10.1038/n35101998
  21. Moayeri M, Leppla SH. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Aspects Med. 2009 Dec;30(6):439-55. Epub 2009 Jul 26. PMID:19638283 doi:10.1016/j.mam.2009.07.003
  22. Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach
  23. Brenda A. Wilson, Abigail A. Salyers, Dixie D. Whitt, and Malcolm E. Winkler. Third Edition. Bacterial Pathogenesis A Molecular Approach
  24. Kenneth Todar, PhD. (2008). http://textbookofbacteriology.net/Anthrax_3.html

Proteopedia Page Contributors and Editors (what is this?)

Peter Aziz, Michal Harel, Alexander Berchansky

Personal tools